Vinge represents Altor in connection with its investment in H2 Green Steel. The investment has been carried out in connection with 1.5 billion euro investment round in H2 Green Steel. Investors participating in the capital raise included, in addition to Altor, inter alia AMF, GIC, Hitachi Energy, Kinnevik, Schaeffler, Andra AP-fonden, FAM, Hy24 and Just Climate.

H2 Green Steel was founded in 2020 with the ambition to accelerate the decarbonization of hard-to-abate industries. The company is starting with steel, which is one of the world’s largest carbon dioxide emitters, building a plant in Boden, northern Sweden. The plant will produce green steel, reducing CO2 emissions with up to 95 percent compared to traditional steelmaking. Groundwork has been in progress at the Boden site since the summer of 2022, and with this transaction, H2 Green Steel is taking a significant step closer to commencing operations by the end of 2025.

Vinge's team consisted mainly of Johan Larsson, Isabelle Wållgren, Robin Fagerström (M&A), Christoffer Nordin, Jolene Reimerson, Elis Allmark (Commercial Agreements), Johan Cederblad, Lina Österberg (Environment), Kristoffer Larson (Real Estate), Mathilda Persson (IT), Mia Falk, Julia Löfqvist (Compliance), Louise Brorsson Salomon, Helena Göransson, Kamyar Najmi (Banking and Finance), Axel Lennartsson (IP), Johan Wahlbom (Competition law), Daniel Wendelsson (Regulatory), Emy Rydén and Ottilia Pettersson (project assistants).



Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023